RLMD Relative Valuation
RLMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RLMD is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.31
P/B
Median3y
1.43
Median5y
2.83
-445.90
FCF Yield
Median3y
-126.15
Median5y
-78.67
Competitors Valuation Multiple
The average P/S ratio for RLMD's competitors is 20.94, providing a benchmark for relative valuation. Relmada Therapeutics Inc Corp (RLMD) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
HAIN
Hain Celestial Group Inc
3.030
USD
+3.77%
PERI
Perion Network Ltd
9.300
USD
-1.90%
ITIC
Investors Title Co
240.680
USD
+3.26%
SHYF
Shyft Group Inc
9.160
USD
+4.81%
AHG
Akso Health Group
1.361
USD
-2.79%
ATXS
Astria Therapeutics Inc
5.360
USD
+3.88%
ORGO
Organogenesis Holdings Inc
5.280
USD
+6.45%
ORKA
Oruka Therapeutics Inc
10.710
USD
+6.14%
MEI
Methode Electronics Inc
6.680
USD
+4.70%
TCMD
Tactile Systems Technology Inc
14.080
USD
+1.81%
FAQ
Is Relmada Therapeutics Inc (RLMD) currently overvalued or undervalued?
Relmada Therapeutics Inc (RLMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.01. The fair price of Relmada Therapeutics Inc (RLMD) is between to according to relative valuation methord.
What is Relmada Therapeutics Inc (RLMD) fair value?
How does RLMD's valuation metrics compare to the industry average?
What is the current P/B ratio for Relmada Therapeutics Inc (RLMD) as of May 04 2025?
What is the current FCF Yield for Relmada Therapeutics Inc (RLMD) as of May 04 2025?
What is the current Forward P/E ratio for Relmada Therapeutics Inc (RLMD) as of May 04 2025?